A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer

This study has been completed.

Study NCT00058552 Information provided by Genentech

First Received: April 8, 2003 Last Updated: December 22, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2005
Estimated Primary Completion Date:	No date given